未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
Cheng, Ying; Pan, Zhanyu; Wu, Lin; Zhu, Bo; Yu, Yan; Zang, Kai; Zhuang, Wu; Liu, Lianke; Gu, Kangsheng; Lian, Juanwen; Chen, Rixin; Bian, Tao; Lin, Dang; Sun, Shenghua; Li, Wei; Hang, Xiaosheng; Jiang, Ou; Zhong, Fukuan; Wang, Rui; Luo, Hui; Shi, Huaqiu; Wei, Zonghui; Zhao, Li; Chen, Shaoshui; Sun, Hongmei; Li, Xingya; Sun, Debin; Ren, Tiejun; Lei, Kaijian; He, Miao; Li, Gaofeng; Liu, Hailong; Li, Runpu; Hu, Chunhong; Kong, Li; Sun, Meili; Xie, Liangzhi; Gai, Wenlin; Chen, Weiqiu; Huang, Zhe; Ren, Wenwen; Su, Huo 分享 收藏 Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)未经治疗的EGFR突变的晚期非小细胞肺癌患者中奥罗替尼与吉非替尼的中枢神经系统疗效: 来自随机III期试验 (AENEAS) 的数据Lu, Shun; Dong, Xiaorong; Jian, Hong; Chen, Jianhua; Chen, Gongyan; Sun, Yuping; Ji, Yinghua; Wang, Ziping; Shi, Jianhua; Lu, Junguo; Chen, Shaoshui; Lv, Dongqing; Zhang, Guojun; Liu, Chunling; Li, Juan; Yu, Xinmin; Lin, Zhong; Yu, Zhuang; Wang, Zhehai; Cui, Jiuwei; Xu, Xingxiang; Fang, Jian; Feng, Jifeng; Xu, Zhi; Ma, Rui; Hu, Jie; Yang, Nong; Zhou, Xiangdong; Wu, Xiaohong; Hu, Chengping; Zhang, Zhihong; Lu, You; Hu, Yanping; Jiang, Liyan; Wang, Qiming; Guo, Renhua; Zhou, Jianying; Li, Baolan; Hu, Chunhong; Tong, Wancheng; Zhang, Helong; Ma, Lin; Chen, Yuan; Jie, Zhijun; Yao, Yu; Zhang, Longzhen; Weng, Jie; Li, Weidong; Xiong, Jianping; Ye, Xianwei; Duan, Jianchun; Yang, Haihua; Sun, Meili; Wei, Hongying; Wei, Jiawei; Zhang, Zheyu; Wu, Qiong 分享 收藏 Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer非小细胞肺癌治疗前情绪困扰与免疫检查点抑制剂反应的关系Zeng, Yue; Hu, Chun-Hong; Li, Yi-Zheng; Zhou, Jian-Song; Wang, Shu-Xing; Liu, Meng-Dong; Qiu, Zhen-Hua; Deng, Chao; Ma, Fang; Xia, Chun-Fang; Liang, Fei; Peng, Yu-Rong; Liang, Ao-Xi; Shi, Sheng-Hao; Yao, Shi-Jiao; Liu, Jun-Qi; Xiao, Wen-Jie; Lin, Xiao-Qiao; Tian, Xin-Yu; Zhang, Ying-Zhe; Tian, Zhuo-Ying; Zou, Ji-An; Li, Yun-Shu; Xiao, Chao-Yue; Xu, Tian; Zhang, Xiao-Jie; Wang, Xiao-Ping; Liu, Xian-Ling; Wu, Fang 分享 收藏 分享 收藏 Efficacy, Safety, and Immunogenicity of TQ-B211 (a Trastuzumab Biosimilar) Plus Docetaxel versus Herceptin® Plus Docetaxel for HER2-positive Metastatic Breast Cancer: a Double-blind, Randomised, Multicenter, Phase 3 TrialHu, Xichun; Zhang, Qingyuan; Wang, Shusen; Sun, Tao; Zeng, Xiaohua; Xie, Weimin; Tong, Zhongsheng; Cao, Hui; Xiong, Huihua; Wang, Xiuwen; Yang, Jin; Zhang, Shuqun; Wang, Ying; Hu, Chunhong; Lei, Kaijian; Ma, Binlin; Liu, Wei; Yu, Zhiyong; Peng, PeiJian; Yang, Hongwei; Yuan, Zhijun; Wang, Xiaojia; Wang, Xujuan; Wang, Hong; Shu, Yongqian; Li, Nanlin; Yue, Wenbin; Wang, Jingfen; Wang, Daqing; Luo, Zhiguo; Mo, Junyang; Li, Yarong; Sheng, Lili 分享 收藏 分享 收藏 分享 收藏 Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC (vol 4, pg 860, 2023)Zhou, Caicun; Wang, Ziping; Sun, Meili; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Sun, Si; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Hu, Chunhong; Liu, Jiwei; Liu, Yunpeng; Wang, Mengzhao; Li, Xingya; Sun, Ping; Shu, Yongqian; Zhou, Jianying; Li, Jingzhang; Gu, Kangsheng; Wang, Changli; Zhao, Hui; Zhang, Yiping; Liu, Chunling; Wang, Jingru; Chen, Rumei; Qin, Mengmeng; Wang, Hao; Yang, Jason 分享 收藏 分享 收藏 Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaDuan, Jianchun; Zhang, Yun; Chen, Ran; Liang, Liang; Huo, Yi; Lu, Shun; Zhao, Jun; Hu, Chunhong; Sun, Yuping; Yang, Kunyu; Chen, Mingwei; Yu, Yan; Ying, Jianming; Huang, Ruiqi; Ma, Xiaopeng; Leaw, Shiangjiin; Bai, Fan; Shen, Zhirong; Cai, Shangli; Gao, Daming; Wang, Jie; Wang, Zhijie 分享 收藏 Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma The JUPITER-02 Randomized Clinical TrialToripalimab联合化疗治疗复发性或转移性鼻咽癌JUPITER-02随机临床试验Mai, Hai-Qiang; Chen, Qiu-Yan; Chen, Dongping; Hu, Chaosu; Yang, Kunyu; Wen, Jiyu; Li, Jingao; Shi, Yingrui; Jin, Feng; Xu, Ruilian; Pan, Jianji; Qu, Shenhong; Li, Ping; Hu, Chunhong; Liu, Yi-Chun; Jiang, Yi; He, Xia; Wang, Hung-Ming; Lim, Wan-Teck; Liao, Wangjun; He, Xiaohui; Chen, Xiaozhong; Wang, Siyang; Yuan, Xianglin; Li, Qi; Lin, Xiaoyan; Jing, Shanghua; Chen, Yanju; Lu, Yin; Hsieh, Ching-Yun; Yang, Muh-Hwa; Yen, Chia-Jui; Samol, Jens; Luo, Xianming; Wang, Xiaojun; Tang, Xiongwen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Xu, Rui-Hua 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLCZhou, Caicun; Wang, Ziping; Sun, Meili; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Sun, Si; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Hu, Chunhong; Liu, Jiwei; Liu, Yunpeng; Wang, Mengzhao; Li, Xingya; Sun, Ping; Shu, Yongqian; Zhou, Jianying; Li, Jingzhang; Gu, Kangsheng; Wang, Changli; Zhao, Hui; Zhang, Yiping; Liu, Chunling; Wang, Jingru; Chen, Rumei; Qin, Mengmeng; Wang, Hao; Yang, Jason 分享 收藏 Longitudinal ctDNA levels and clinical outcomes of first-line (1L) tislelizumab (TIS) plus chemotherapy (chemo) treatment for advanced non-small cell lung cancer (NSCLC) in the RATIONALE-304 and 307 studiesLu, Shun; Wang, Jie; Sun, Meili; Zhao, Jun; Hu, Chunhong; Wang, Mengzhao; Zhou, Jianying; Song, Yong; Zhou, Qinghua; Zhang, Jiayuan; Shi, Yang; Huang, Ruiqi; Wu, Xikun; He, Wanyu; Qu, Xiaofei; Zhang, Yun; Shen, Zhirong; Yu, Yan 分享 收藏 Genomic profiles and immune cell infiltration landscapes for lymph node metastasis in T1 lung adenocarcinomaWu, Fang; Pan, Yue; Hu, Chunhong; Chen, Chen; Liu, Wenliang; Fan, Songqing; Shu, Long; Zhao, Lishu; Fu, Yucheng; Zhang, Sujuan; Liu, Junqi; Zeng, Yue; Peng, Yurong; Zang, Hongjing; Deng, Chao; Qiu, Zhenhua; Ma, Fang; Yu, Fenglei; Liu, Xianling; Liu, Lijuan; Yang, Lingling; Shao, Yang 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
